X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
male (6) 6
index medicus (4) 4
middle aged (4) 4
adult (3) 3
colorectal cancer (3) 3
research (3) 3
treatment outcome (3) 3
administration, oral (2) 2
aged (2) 2
antineoplastic agents - therapeutic use (2) 2
cancer (2) 2
cardiovascular events (2) 2
care and treatment (2) 2
cetuximab (2) 2
clinical trials (2) 2
colorectal neoplasms - genetics (2) 2
colorectal neoplasms - mortality (2) 2
colorectal neoplasms - pathology (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
endocrinology & metabolism (2) 2
genetic aspects (2) 2
glycine - adverse effects (2) 2
glycine - analogs & derivatives (2) 2
glycine - therapeutic use (2) 2
hypoglycemic agents - therapeutic use (2) 2
immunology (2) 2
infectious diseases (2) 2
insulin (2) 2
metastasis (2) 2
metformin - therapeutic use (2) 2
microsatellite instability (2) 2
mutation (2) 2
nivolumab (2) 2
oncology (2) 2
oxazoles - adverse effects (2) 2
oxazoles - therapeutic use (2) 2
type 2 diabetes (2) 2
1st-line treatment (1) 1
3-day intramuscular ceftriaxone (1) 1
abridged index medicus (1) 1
acidosis, lactic (1) 1
acute disease (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
aged, 80 and over (1) 1
amoxicillin/clavulanate (1) 1
analysis (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antiretroviral therapy (1) 1
antiviral activity (1) 1
antiviral agents (1) 1
arthropathy (1) 1
article (1) 1
bacterial eradication (1) 1
blood glucose - drug effects (1) 1
blood glucose - metabolism (1) 1
braf mutation (1) 1
calcium (1) 1
cancer therapies (1) 1
carcinoma - drug therapy (1) 1
carcinoma - genetics (1) 1
carcinoma - secondary (1) 1
cd4 lymphocyte count (1) 1
cephalosporins (1) 1
cetuximab plus irinotecan (1) 1
chemotherapy (1) 1
child, preschool (1) 1
children (1) 1
cholesterol, hdl - blood (1) 1
ciprofloxacin (1) 1
clinical-trial (1) 1
clinical-trials (1) 1
codon - genetics (1) 1
codon, nonsense (1) 1
colorectal carcinoma (1) 1
colorectal neoplasms - drug therapy (1) 1
comparative studies (1) 1
compassionate use (1) 1
criteria (1) 1
deficiency (1) 1
deoxyribonucleic acid--dna (1) 1
development and progression (1) 1
diabetes (1) 1
diabetes mellitus, type 2 - blood (1) 1
diabetes mellitus, type 2 - metabolism (1) 1
diabetes mellitus, type 2 - mortality (1) 1
diagnosis (1) 1
didanosine - adverse effects (1) 1
didanosine - therapeutic use (1) 1
disease control (1) 1
disease transmission (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2018, Volume 36, Issue 8, pp. 773 - 779
PurposeNivolumab provides clinical benefit (objective response rate [ORR], 31%; 95% CI, 20.8 to 42.9; disease control rate, 69%; 12-month overall survival... 
CRITERIA | MULTICENTER | MELANOMA | SOLID TUMORS | ONCOLOGY | PD-1 BLOCKADE | OPEN-LABEL | QUALITY-OF-LIFE | DEFICIENCY | GUIDELINE
Journal Article
Journal Article
Diabetes & Vascular Disease Research, ISSN 1479-1641, 09/2008, Volume 5, Issue 3, pp. 168 - 176
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 06/2006, Volume 42, Issue 2, pp. 169 - 176
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.